Inpatient Psychiatric Hospital Facility Quality Reporting Program
Keywords
Quality Reporting Programs
Quality Reporting Payments
Quality of Care Information
Eligible Psychiatric Hospitals
Psychiatric Hospital
Psychiatric Services
CMS Hospital Compare
Psychiatric Hospital Facilities
Inpatient Psychiatric Hospital Facility Quality Measures by National
This dataset includes the psychiatric facilities that are eligible for the Inpatient Psychiatric Facility Quality Reporting (IPFQR) program are required to meet all program requirements, otherwise their Medicare payments may be reduced. It contains national data for the hospitals in United States for several inpatient psychiatric facility quality measures.
John Snow Labs Standard End User License Agreement
Last updated:January 20, 2021
This Standard End User License Agreement (“EULA”) applies to customers of John Snow Labs Inc. (as defined below), using any product of John Snow Labs Inc. on John Snow Labs Marketplace as defined below (hereinafter referred to “you”) and John Snow Labs Inc., a Delaware corporation (“John Snow Labs”, “we” or “us”).
By downloading, installing, and/or using (as applicable) any Product of John Snow Labs (as defined below), you automatically agree to be bound by, and use our Products in compliance with, this EULA. This EULA, together with additional terms and conditions and/or policies referenced herein or located on https://www.johnsnowlabs.com and/or conveyed to you by John Snow Labs, is a legally binding contract between you and John Snow Labs.
PLEASE READ THIS EULA CAREFULLY BEFORE PURCHASING, INSTALLING OR USING OUR PRODUCTS MADE AVAILABLE ON JOHN SNOW LABS MARKETPLACE.
We may make changes to this EULA from time to time. When we do so, we will revise the “last updated” date given above. The then-current version of this EULA will supersede all earlier versions. You agree that your continued use of our Products after such changes have been published to our EULA will constitute your acceptance of such revised EULA.
“Products” means products and services of John Snow Labs that you download and use from listings in John Snow Labs Data Library;
Important Notice
By installing and using our Products, you acknowledge that the use of the Products can be subject to the restrictions and controls imposed by United States export regulations.
You represent and warrant that you do not intend to use the Products for any purpose prohibited by United States export regulations, including, without limitation, terrorism, cyber-attacks, cyber-crimes, money-laundering, industrial espionage, or nuclear, chemical or biological weapons proliferation. Further, you represent and warrant that you are not listed as a denied party on any list governing United States exports.
Eligibility
Our Products can be used by an individual, business or other legal entity, or both. If you are entering into this EULA, or using the Products, on behalf of a company or other legal entity, you represent that you have the authority to bind such entity to this EULA, in which case “you” shall refer to such entity.
In the event you have entered into a separate written agreement with John Snow Labs regarding the Products that contemplates terms that are inconsistent with this EULA, the written agreement shall control and this EULA will not apply to you to the extent inconsistent with such written agreement, or, if such written agreement is contemplated to be in lieu of this EULA, then this EULA shall not apply at all.
Your Access and Use
Subject to your compliance with this EULA, as well as any other applicable policies, John Snow Labs grants you non-exclusive, non-transferable, license to install, access to, modify, and use of, the Products worldwide (subject to applicable export laws) during the term of this EULA (as described below) solely for research, private study and personal use of Products.
This license is personal to you, and you may not resell our Products, permit other users access to our Products through your account. Your right to use our Products is limited by all terms and conditions set forth in this EULA.
Except for your pre-existing rights and this license granted to you, we and our licensors retain all rights, titles and interests in and to our Products, all related intellectual property rights, including trademarks (whether registered or pending), domain and business names. Our Products are protected by applicable intellectual property laws, including United States copyright law and international treaties.
Except for the foregoing license, you have no other rights in the Products and you may not modify, edit, copy, reproduce, create derivative works of, reverse engineer, alter, enhance or in any way exploit the Products in any manner. If you breach any of this EULA, the above license will terminate automatically.
You will be deemed to have taken any action that you permit, assist or facilitate any person or entity to take related to this EULA, your content or use of the Products. You are responsible for end users’ use of your content and the Products. You will ensure that all end users comply with your obligations under this EULA and that the terms of your agreement with each end user are consistent with this EULA. If you become aware of any violation of your obligations under this EULA caused by an end user, you will immediately suspend access to your content and the Products by such end user. We do not provide any support or services to end users unless we have a separate agreement with you or an end user obligating us to provide such support or services.
Restrictions
You will access or use our Products solely via John Snow Labs Data Library.
Except as otherwise explicitly provided in this EULA or as may be expressly permitted by applicable law, you will not, and will not permit or authorize any third party to:
reproduce, modify, translate, enhance, decompile, disassemble, reverse engineer or create derivative works of any of our Products or its technological features or measures;
rent, lease, sell, resell, loan, distribute, or sublicense access to any of our Products;
circumvent or disable any security or technological features or measures of our Products;
use our intellectual property rights without our express prior written authorization;
use our Products for more than one trial period, unless the trial period is extended by John Snow Labs’ prior written permit;
use our Products with an intent to build a competitive product or service, or copy or substantially copy any ideas, features, functions, organization, structure, application program interface, graphics, or user interface of the Products;
store, copy, modify, distribute, or resell any of the information; audio, visual, and audiovisual works, or other content made available on our Products (collectively, “Content”) or compile or collect any Content as part of a database or other work;
use any automated tool (e.g., robots, spiders) to access or use our Products, or to store, copy, modify, distribute, or resell any Content;
circumvent or disable any rights management, usage rules, or other security features of our Products;
use our Products in a manner that overburdens, or that threatens the integrity, performance, or availability of, our Products; or
remove, alter, or obscure any proprietary notices (including copyright and trademark notices) on any portion of our Products or any Content.
Fees and Taxes
Your use of the Products is subject to our fees. All fees are given on our website https://www.johnsnowlabs.com. Except as set forth in this EULA, the fees are non-refundable. We are entitled to revise our fees from time to time.
The fees exclude any federal, state or local taxes, VAT, GST, or similar taxes. You are responsible for identification and payment of all taxes as required by applicable law.
Term and Termination
This EULA will become effective as of the date of your order of Products and shall be in effect until terminated.
John Snow Labs may suspend or terminate your right to use our Products, if you or your end user’s use of the Products:
is in breach of this EULA;
poses a security risk to our Products;
could adversely impact our systems, the Products or other customers;
could subject us, our affiliates, or any third party to liability; or
could be fraudulent.
We may also suspend or terminate your right to use our Products, if you fail to perform your payment obligations, or you have ceased to operate in the ordinary course, made an assignment for the benefit of creditors or similar disposition of your assets, or become the subject of any bankruptcy, reorganization, liquidation, dissolution or similar proceeding.
We may also suspend or terminate your right to use our Products without any reason upon a relevant 30 days’ written notice to you and will refund the unused fees pre-paid by you for access to the Products for the affected time period (if any). Where your access is suspended or terminated by the breach of this EULA or applicable laws, John Snow Labs will will not provide, or be liable for, any refund.
You will cease use of the Products during any period of suspension, or upon termination of this EULA.
All provisions which by their nature are intended to survive termination shall survive termination of this EULA.
Support
If applicable to your Product, John Snow Labs will provide you with the support services. If you use a trial access, support services are excluded. Under this EULA, our support services exclude any installation, training, maintenance services (including any error corrections, bug fixes, or new releases), technical assistance, consulting services, or other services of any kind. Such services are provided at John Snow Labs’ discretion.
From time to time John Snow Labs can perform updates to our software. If available, such updates may include bug fixes, new features and/or enhancements. You are solely responsible for deploying such updates at your own risk and liability.
Access to our Products
We do not provide you with the equipment to access our Products. You are responsible for all fees charged by third parties related to your access and use of our Products (e.g., charges by Internet service providers).
You are responsible for monitoring your use of the Products, including payment of all fees and/or taxes related to such access and use. You agree that John Snow Labs is permitted to request and you hereby consent to provide John Snow Labs information related to your use of the Products for auditing purposes.
You also certify that you are legally permitted to use the Products, and take full responsibility for the selection and use of the Products. This EULA is void where prohibited by law, and the right to use the Products is revoked in such jurisdictions. John Snow Labs makes no claim that the Products may be lawfully used outside of the United States. If you use the Products from outside of the United States, you do so at your own risk and you are responsible for compliance with the laws of jurisdiction.
Privacy Policy
We may collect, store and receive personal and other information about you through our Products. Our collection and use of this information is governed by our Privacy Policy available at https://www.JohnSnowLabs.com/privacy/ which may be amended from time to time.
Links and Third Party Content
Our Products may display, or contain links to, third party products, services, and websites. Any opinions, advice, statements, services, offers, or other information that constitutes part of the content expressed, authored, or made available by other users or other third parties, or which is accessible through or may be located using our Products (collectively, “Third Party Content”) are those of the respective authors or producers and not of us or our shareholders, directors, officers, employees, agents, or representatives.
We do not control Third Party Content and do not guarantee the accuracy, integrity or quality of such Third Party Content. We are not responsible for the performance of, we do not endorse, and we are not responsible or liable for, any Third Party Content or any information or materials advertised in any Third Party Content. By using our Products, you may be exposed to content that is offensive, indecent, or objectionable. We are not responsible or liable, directly or indirectly, for any damage or loss caused to you by your use of or reliance on any goods, services, or information available on or through any third party service or Third Party Content. It is your responsibility to evaluate the information, opinion, advice, or other content available on and through our Products.
Proprietary Rights
John Snow Labs will not obtain any rights under this EULA from you (or your licensors) to your content.
The Products, including software, is and remains the exclusive property of John Snow Labs and its licensors. Except for the access and use rights expressly set forth in this EULA, no license or other rights in or to the Products or John Snow Labs trademark(s) and other intellectual property rights therein, are granted to you, and all such licenses and rights are expressly reserved. You will not remove, alter, or obscure any proprietary notices (including copyright and trademark notices) on any portion of our Products or any Content.
Trademarks
“John Snow Labs,” the John Snow Labs logo, and any other product, business or service name or slogan, whether registered or pending, displayed on our Products are trademarks of John Snow Labs, Inc. or its suppliers or licensors, and may not be copied, imitated or used, in whole or in part, without the prior written permission of John Snow Labs or the applicable trademark holder. You may not use any metatags or any other “hidden text” utilizing “John Snow Labs” or any other name, trademark or product, business or service name of John Snow Labs without our prior written permission. In addition, the look and feel of our Products, including all page headers, custom graphics, button icons and scripts, is the service mark, trademark and/or trade dress of John Snow Labs and may not be copied, imitated or used, in whole or in part, without our prior written permission. All other trademarks, pending trademarks, registered trademarks, product names and company names or logos mentioned in our Products are the property of John Snow Labs Inc. and/or their respective owners. Reference to any products, services, processes or other information, by trade name, trademark, manufacturer, supplier, or otherwise does not constitute or imply endorsement, sponsorship, or recommendation thereof by us.
Disclaimer of Warranties
YOUR USE OF THE PRODUCTS IS AT YOUR SOLE RISK. THE PRODUCTS AND CONTENT EACH ARE PROVIDED ON AN “AS IS” AND “AS AVAILABLE” BASIS. WE AND OUR SUPPLIERS AND LICENSORS EXPRESSLY DISCLAIM ALL WARRANTIES OF ANY KIND, WHETHER EXPRESS OR IMPLIED, INCLUDING, BUT NOT LIMITED TO THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, TITLE, AND NON-INFRINGEMENT. WE DO NOT GUARANTEE THE ACCURACY, COMPLETENESS, OR USEFULNESS OF THE PRODUCTS OR ANY CONTENT, AND YOU RELY ON THE PRODUCTS AND CONTENT AT YOUR OWN RISK. ANY MATERIAL THAT YOU ACCESS OR OBTAIN THROUGH OUR PRODUCTS IS DONE AT YOUR OWN DISCRETION AND RISK AND YOU WILL BE SOLELY RESPONSIBLE FOR ANY DAMAGE TO YOUR COMPUTER OR LOSS OF DATA THAT RESULTS FROM THE DOWNLOAD OF ANY MATERIAL THROUGH OUR PRODUCTS. NO ADVICE OR INFORMATION, WHETHER ORAL OR WRITTEN, OBTAINED BY YOU FROM US OR THROUGH OR FROM OUR PRODUCTS WILL CREATE ANY WARRANTY NOT EXPRESSLY STATED IN THIS EULA. SOME STATES MAY PROHIBIT A DISCLAIMER OF WARRANTIES AND YOU MAY HAVE OTHER RIGHTS THAT VARY FROM STATE TO STATE.
Limitation of Liability
WE AND OUR SUPPLIERS AND LICENSORS WILL NOT BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR EXEMPLARY DAMAGES, INCLUDING BUT NOT LIMITED TO, DAMAGES FOR LOSS OF PROFITS, GOODWILL, USE, DATA, OR OTHER INTANGIBLE LOSSES (EVEN IF WE HAVE BEEN ADVISED OF THE POSSIBILITY OF THESE DAMAGES), RESULTING FROM YOUR USE OF OUR PRODUCTS AND CONTENT. UNDER NO CIRCUMSTANCES WILL THE TOTAL LIABILITY OF US AND OUR SUPPLIERS AND LICENSORS OF ALL KINDS ARISING OUT OF OR RELATED TO YOUR USE OF THE PRODUCTS AND CONTENT (INCLUDING BUT NOT LIMITED TO WARRANTY CLAIMS), REGARDLESS OF THE FORUM AND REGARDLESS OF WHETHER ANY ACTION OR CLAIM IS BASED ON CONTRACT, TORT, OR OTHERWISE, EXCEED THE AMOUNTS, IF ANY, THAT YOU HAVE PAID FOR YOUR USE OF THE PRODUCTS AND CONTENT. BECAUSE SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF LIABILITY FOR CONSEQUENTIAL OR INCIDENTAL DAMAGES, THE ABOVE LIMITATION MAY NOT APPLY TO YOU.
Indemnity
To the full extent permitted by applicable law, you shall defend, indemnify and hold harmless John Snow Labs, its affiliates and its licensors, and each of their respective employees, officers, directors, and representatives from and against any claims, damages, losses, liabilities, costs, and expenses (including reasonable attorney’s fees) arising out of or relating to any third party claim concerning: (a) your use of the Products; (b) breach of this EULA or violation of applicable law by you; (c) any content or the combination of such content with other software, content or processes, including any claim involving alleged infringement or misappropriation of third-party rights by such content or combination; or (d) breach of any obligation or duty you owe to a third party.
Legal Notices
Enforcement of this EULA will be governed by the laws of the State of Delaware, excluding its conflict and choice of law principles. The exclusive jurisdiction and venue for any claims arising out of or related to this EULA or your use of the Products will lie in the state and federal courts located in Sussex County, within the State of Delaware, and you irrevocably agree to submit to the jurisdiction of such courts. Our failure to enforce any right or provision in this EULA will not constitute a waiver of such right or provision unless acknowledged and agreed by us in writing. In the event that a court of competent jurisdiction finds any provision of this EULA to be illegal, invalid, or unenforceable, the remaining provisions will remain in full force and effect.
Notifications
We may use your contact information to notify you if we have any legitimate interest or if we need to notify you on any important information related to your use of Products. We will not send you newsletters unless you expressly consented to such notifications.
Contacting Us
If you have any questions or concerns about our Products or this EULA, you may contact us by email at support@JohnSnowLabs.com.
The Inpatient Psychiatric Hospital Facility Quality Reporting (IPFQR) program is being developed as mandated by section 1886(s)(4) of the Social Security Act (SSA), as added and amended by Sections 3401(f) and 10322(a) of the Affordable Care Act (Pub.L. 111-148).
The IPFQR program is a pay-for-reporting program intended to equip consumers with quality of care information to make more informed decisions about healthcare options. It is also intended to encourage hospitals and clinicians to improve the quality of inpatient care provided to beneficiaries by, first, ensuring that providers are aware of and reporting on best practices for their respective facilities and type of care. Because this is a pay-for-reporting program, facilities will be subject to payment reduction for non-participation. Eligible hospitals that do not participate in the IPFQR program in a fiscal year will receive a 2.0 percentage point reduction to their annual update to their standard federal rate for that year. The reduction is noncumulative across payment years.
The IPFQR program requires facilities to submit data for specific inpatient psychiatric clinical process measures. These quality measures will be announced no later than October 1, 2012. To meet the IPFQR program requirement, Inpatient Psychiatric Hospital Facilities (IPFs) will be required to submit all quality measures in the form, manner, and time as specified by the Secretary, to the Centers for Medicare & Medicaid Services (CMS), beginning with Fiscal Year (FY) 2014 payment determination year and subsequent fiscal years. Participating IPFs must comply with the program requirements, which will be set forth through rule-making, including public reporting of the measure rates.
About this Dataset
Data Info
Date Created
2014-01-28
Last Modified
2022-10-04
Version
2022-10-26
Update Frequency
Quarterly
Temporal Coverage
2014-2022
Spatial Coverage
United States
Source
John Snow Labs; Centers for Medicare & Medicaid Services;
Description of Hospital Based Inpatient Psychiatric Services Core Measure Set. HBIPS2 is described as Hours of Physical Restraint Use. Total hours all patients spent in physical restraint as a proportion of total inpatient hours.
string
-
National_HBIPS2_Overall_Rate_Per_1000
Indicates the overall rate per 1000 for HBIPS2 Measure.
number
level : Ratio
National_HBIPS2_Overall_Numerator
Indicates the overall Numerator value for HBIPS2 Measure.
number
level : Ratio
National_HBIPS2_Overall_Denominator
Indicates the overall Denominator value for HBIPS2 Measure.
integer
level : Ratio
National_HBIPS2_1_to_12_Rate_Per_1000
Indicates the HBIPS2 Measure Rate per 1000 for children (1-12 Years)
number
level : Ratio
National_HBIPS2_1_to_12_Numerator
Indicates the Numerator values for HBIPS2 Measure for children (1-12 Years)
number
level : Ratio
National_HBIPS2_1_to_12_Denominator
Indicates the Denominator values for HBIPS2 Measure for children (1-12 Years)
integer
level : Ratio
National_HBIPS2_13_to_17_Rate_Per_1000
Indicates the HBIPS2 Measure Rate per 1000 for Adolescent (13-17 Years).
number
level : Ratio
National_HBIPS2_13_to_17_Numerator
Indicates the Numerator values for HBIPS2 Measure for Adolescent (13-17 Years).
number
level : Ratio
National_HBIPS2_13_to_17_Denominator
Indicates the Denominator values for HBIPS2 Measure for Adolescent (13-17 Years).
integer
level : Ratio
National_HBIPS2_18_to_64_Rate_Per_1000
Indicates the HBIPS2 Measure Rate per 1000 for Adult (18-64 Years).
number
level : Ratio
National_HBIPS2_18_to_64_Numerator
Indicates the Numerator values for HBIPS2 Measure for Adult (18-64 Years).
number
level : Ratio
National_HBIPS2_18_to_64_Denominator
Indicates the Denominator values for HBIPS2 Measure for Adult (18-64 Years).
integer
level : Ratio
National_HBIPS2_65_Over_Rate_Per_1000
Indicates the HBIPS2 Measure Rate per 1000 for Older Adult (> 65 Years).
number
level : Ratio
National_HBIPS2_65_Over_Numerator
Indicates the Numerator values for HBIPS2 Measure for Older Adult (> 65 Years).
number
level : Ratio
National_HBIPS2_65_Over_Denominator
Indicates the Denominator values for HBIPS2 Measure for Older Adult (> 65 Years).
integer
level : Ratio
National_HBIPS3_Measure_Description
Description of Hospital Based Inpatient Psychiatric Services Core Measure Set. HBIPS3 is described as Hours of Seclusion Use. Total hours all patients spent in seclusion as a proportion of total inpatient hours.
string
-
National_HBIPS3_Overall_Rate_Per_1000
Indicates the Numerator values for HBIPS3 Measure for children (1-12 Years)
number
level : Ratio
National_HBIPS3_Overall_Numerator
Indicates the Numerator values for HBIPS3 Measure for children (1-12 Years)
number
level : Ratio
National_HBIPS3_Overall_Denominator
Indicates the Numerator values for HBIPS3 Measure for children (1-12 Years)
number
level : Ratio
National_HBIPS3_1_to_12_Rate_Per_1000
Indicates the HBIPS3 Measure Rate per 1000 for children (1-12 Years)
number
level : Ratio
National_HBIPS3_1_to_12_Numerator
Indicates the Numerator values for HBIPS3 Measure for children (1-12 Years)
number
level : Ratio
National_HBIPS3_1_to_12_Denominator
Indicates the Denominator values for HBIPS3 Measure for children (1-12 Years)
integer
level : Ratio
National_HBIPS3_13_to_17_Rate_Per_1000
Indicates the HBIPS3 Measure Rate per 1000 for Adolescent (13-17 Years).
number
level : Ratio
National_HBIPS3_13_to_17_Numerator
Indicates the Numerator values for HBIPS3 Measure for Adolescent (13-17 Years).
number
level : Ratio
National_HBIPS3_13_to_17_Denominator
Indicates the Denominator values for HBIPS3 Measure for Adolescent (13-17 Years).
integer
level : Ratio
National_HBIPS3_18_to_64_Rate_Per_1000
Indicates the HBIPS3 Measure Rate per 1000 for Adult (18-64 Years).
number
level : Ratio
National_HBIPS3_18_to_64_Numerator
Indicates the Numerator values for HBIPS3 Measure for Adult (18-64 Years).
number
level : Ratio
National_HBIPS3_18_to_64_Denominator
Indicates the Denominator values for HBIPS3 Measure for Adult (18-64 Years).
integer
level : Ratio
National_HBIPS3_65_Over_Rate_Per_1000
Indicates the HBIPS3 Measure Rate per 1000 for Older Adult (> 65 Years).
number
level : Ratio
National_HBIPS3_65_Over_Numerator
Indicates the Numerator values for HBIPS3 Measure for Older Adult (> 65 Years).
number
level : Ratio
National_HBIPS3_65_Over_Denominator
Indicates the Denominator values for HBIPS3 Measure for Older Adult (> 65 Years).
integer
level : Ratio
National_HBIPS4_Measure_Description
Description of Hospital Based Inpatient Psychiatric Services Core Measure Set. HBIPS4 is described as Patients discharged on multiple antipsychotic medications.
string
-
National_HBIPS4_Overall_Percent_of_Total
Indicates the overall percentage for HBIPS4 Measure.
number
level : Ratio
National_HBIPS4_Overall_Numerator
Indicates the overall Numerator value for HBIPS4 Measure.
integer
level : Ratio
National_HBIPS4_Overall_Denominator
Indicates the overall Denominator value for HBIPS4 Measure.
integer
level : Ratio
National_HBIPS4_1_to_12_Percent_of_Total
Indicates the overall percentage of HBIPS4 Measure for children (1-12 Years)
number
level : Ratio
National_HBIPS4_1_to_12_Numerator
Indicates the Numerator values for HBIPS4 Measure for children (1-12 Years)
integer
level : Ratio
National_HBIPS4_1_to_12_Denominator
Indicates the Denominator values for HBIPS4 Measure for children (1-12 Years)
integer
level : Ratio
National_HBIPS4_13_to_17_Percent_of_Total
Indicates the overall percentage of HBIPS4 Measure for Adolescent (13-17 Years).
number
level : Ratio
National_HBIPS4_13_to_17_Numerator
Indicates the Numerator values for HBIPS4 Measure for Adolescent (13-17 Years).
integer
level : Ratio
National_HBIPS4_13_to_17_Denominator
Indicates the Denominator values for HBIPS4 Measure for Adolescent (13-17 Years).
integer
level : Ratio
National_HBIPS4_18_to_64_Percent_of_Total
Indicates the overall percentage of HBIPS4 Measure for Adult (18-64 Years).
number
level : Ratio
National_HBIPS4_18_to_64_Numerator
Indicates the Numerator values for HBIPS4 Measure for Adult (18-64 Years).
integer
level : Ratio
National_HBIPS4_18_to_64_Denominator
Indicates the Denominator values for HBIPS4 Measure for Adult (18-64 Years).
integer
level : Ratio
National_HBIPS4_65_Over_Percent_of_Total
Indicates the overall percentage of HBIPS4 Measure for Older Adult (> 65 Years).
number
level : Ratio
National_HBIPS4_65_Over_Numerator
Indicates the Numerator values for HBIPS4 Measure for Older Adult (> 65 Years).
integer
level : Ratio
National_HBIPS4_65_Over_Denominator
Indicates the Denominator values for HBIPS4 Measure for Older Adult (> 65 Years).
integer
level : Ratio
National_HBIPS5_Measure_Description
Description of Hospital Based Inpatient Psychiatric Services Core Measure Set. HBIPS5 is described as Patients discharged on multiple antipsychotic medications with appropriate justification.Percent of patients discharged on multiple antipsychotic medications with appropriate justification as a proportion of patients discharged on two or more antipsychotic medications. Appropriate justifications are limited to augmentation of clozapine, tapering to monotherapy, and history of at least three failed trials of monotherapy.
string
-
National_HBIPS5_Overall_Percent_of_Total
Indicates the overall percentage for HBIPS5 Measure.
number
level : Ratio
National_HBIPS5_Top_10_Percent
Indicates the top 10 percentage for HBIPS5 Measure.
integer
level : Ratio
National_HBIPS5_Overall_Numerator
Indicates the overall Numerator value for HBIPS5 Measure.
integer
level : Ratio
National_HBIPS5_Overall_Denominator
Indicates the overall Denominator value for HBIPS5 Measure.
integer
level : Ratio
National_HBIPS5_1_to_12_Percent_of_Total
Indicates the overall percentage of HBIPS5 Measure for children (1-12 Years)
number
level : Ratio
National_HBIPS5_1_to_12_Numerator
Indicates the Numerator values for HBIPS5 Measure for children (1-12 Years)
integer
level : Ratio
National_HBIPS5_1_to_12_Denominator
Indicates the Denominator values for HBIPS5 Measure for children (1-12 Years)
integer
level : Ratio
National_HBIPS5_13_to_17_Percent_of_Total
Indicates the overall percentage of HBIPS5 Measure for Adolescent (13-17 Years).
number
level : Ratio
National_HBIPS5_13_to_17_Numerator
Indicates the Numerator values for HBIPS5 Measure for Adolescent (13-17 Years).
integer
level : Ratio
National_HBIPS5_13_to_17_Denominator
Indicates the Denominator values for HBIPS5 Measure for Adolescent (13-17 Years).
integer
level : Ratio
National_HBIPS5_18_to_64_Percent_of_Total
Indicates the overall percentage of HBIPS5 Measure for Adult (18-64 Years).
number
level : Ratio
National_HBIPS5_18_to_64_Numerator
Indicates the Numerator values for HBIPS5 Measure for Adult (18-64 Years).
integer
level : Ratio
National_HBIPS5_18_to_64_Denominator
Indicates the Denominator values for HBIPS5 Measure for Adult (18-64 Years).
integer
level : Ratio
National_HBIPS5_65_Over_Percent_of_Total
Indicates the overall percentage of HBIPS5 Measure for Older Adult (> 65 Years).
number
level : Ratio
National_HBIPS5_65_Over_Numerator
Indicates the Numerator values for HBIPS5 Measure for Older Adult (> 65 Years).
integer
level : Ratio
National_HBIPS5_65_Over_Denominator
Indicates the Denominator values for HBIPS5 Measure for Older Adult (> 65 Years).
integer
level : Ratio
National_HBIPS6_Measure_Description
Description of Hospital Based Inpatient Psychiatric Services Core Measure Set. HBIPS6 is described as Post discharge continuing care plan created.
string
-
National_HBIPS6_Overall_Percent_of_Total
Indicates the overall percentage for HBIPS6 Measure.
number
level : Ratio
National_HBIPS6_Overall_Numerator
Indicates the overall Numerator value for HBIPS6 Measure.
integer
level : Ratio
National_HBIPS6_Overall_Denominator
Indicates the overall Denominator value for HBIPS6 Measure.
integer
level : Ratio
National_HBIPS6_1_to_12_Percent_of_Total
Indicates the overall percentage of HBIPS6 Measure for children (1-12 Years)
number
level : Ratio
National_HBIPS6_1_to_12_Numerator
Indicates the Numerator values for HBIPS6 Measure for children (1-12 Years)
integer
level : Ratio
National_HBIPS6_1_to_12_Denominator
Indicates the Denominator values for HBIPS6 Measure for children (1-12 Years)
integer
level : Ratio
National_HBIPS6_13_to_17_Percent_of_Total
Indicates the overall percentage of HBIPS6 Measure for Adolescent (13-17 Years).
number
level : Ratio
National_HBIPS6_13_to_17_Numerator
Indicates the Numerator values for HBIPS6 Measure for Adolescent (13-17 Years).
integer
level : Ratio
National_HBIPS6_13_to_17_Denominator
Indicates the Denominator values for HBIPS6 Measure for Adolescent (13-17 Years).
integer
level : Ratio
National_HBIPS6_18_to_64_Percent_of_Total
Indicates the overall percentage of HBIPS6 Measure for Adult (18-64 Years).
number
level : Ratio
National_HBIPS6_18_to_64_Numerator
Indicates the Numerator values for HBIPS6 Measure for Adult (18-64 Years).
integer
level : Ratio
National_HBIPS6_18_to_64_Denominator
Indicates the Denominator values for HBIPS6 Measure for Adult (18-64 Years).
integer
level : Ratio
National_HBIPS6_65_Over_Percent_of_Total
Indicates the overall percentage of HBIPS6 Measure for Older Adult (> 65 Years).
number
level : Ratio
National_HBIPS6_65_Over_Numerator
Indicates the Numerator values for HBIPS6 Measure for Older Adult (> 65 Years).
number
level : Ratio
National_HBIPS6_65_Over_Denominator
Indicates the Denominator values for HBIPS6 Measure for Older Adult (> 65 Years).
integer
level : Ratio
National_HBIPS7_Measure_Description
Description of Hospital Based Inpatient Psychiatric Services Core Measure Set. HBIPS7 is described as Post discharge continuing care plan transmitted to next level of care provider upon discharge.
string
-
National_HBIPS7_Overall_Percent_of_Total
Indicates the overall percentage for HBIPS7 Measure.
number
level : Ratio
National_HBIPS7_Overall_Numerator
Indicates the overall Numerator value for HBIPS7 Measure.
integer
level : Ratio
National_HBIPS7_Overall_Denominator
Indicates the overall Denominator value for HBIPS7 Measure.
integer
level : Ratio
National_HBIPS7_1_to_12_Percent_of_Total
Indicates the overall percentage of HBIPS7 Measure for children (1-12 Years)
number
level : Ratio
National_HBIPS7_1_to_12_Numerator
Indicates the Numerator values for HBIPS7 Measure for children (1-12 Years)
integer
level : Ratio
National_HBIPS7_1_to_12_Denominator
Indicates the Denominator values for HBIPS7 Measure for children (1-12 Years)
integer
level : Ratio
National_HBIPS7_13_to_17_Percent_of_Total
Indicates the overall percentage of HBIPS7 Measure for Adolescent (13-17 Years).
number
level : Ratio
National_HBIPS7_13_to_17_Numerator
Indicates the Numerator values for HBIPS7 Measure for Adolescent (13-17 Years).
integer
level : Nominal
National_HBIPS7_13_to_17_Denominator
Indicates the Denominator values for HBIPS7 Measure for Adolescent (13-17 Years).
integer
level : Nominal
National_HBIPS7_18_to_64_Percent_of_Total
Indicates the overall percentage of HBIPS7 Measure for Adult (18-64 Years).
number
level : Ratio
National_HBIPS7_18_to_64_Numerator
Indicates the Numerator values for HBIPS7 Measure for Adult (18-64 Years).
integer
level : Ratio
National_HBIPS7_18_to_64_Denominator
Indicates the Denominator values for HBIPS7 Measure for Adult (18-64 Years).
integer
level : Ratio
National_HBIPS7_65_Over_Percent_of_Total
Indicates the overall percentage of HBIPS7 Measure for Older Adult (> 65 Years).
number
level : Ratio
National_HBIPS7_65_Over_Numerator
Indicates the Numerator values for HBIPS7 Measure for Older Adult (> 65 Years).
integer
level : Ratio
National_HBIPS7_65_Over_Denominator
Indicates the Denominator values for HBIPS7 Measure for Older Adult (> 65 Years)..
integer
level : Ratio
National_SMD_Measure_Description
Description of Screening for Metabolic Disorders (SMD) Measure.
string
-
National_SMD_Percent
Indicates the overall percentage for Screening for Metabolic Disorders (SMD) Measure.
integer
level : Ratio
National_SMD_Top_10_Percent
Indicates the top 10 percentage of Screening for Metabolic Disorders (SMD) Measure.
integer
level : Ratio
National_SUB1_Measure_Description
Description of Substance Use Treatment Measure. SUB1 is described as Alcohol Use Screening. Measures the percent of patients age 18 years or older who were screened for alcohol use, using a validated screening questionnaire for unhealthy alcohol use within three days of admission as a proportion of patients discharged.
string
-
National_SUB1_Percent
Indicates the overall percentage for SUB1 Measure.
number
level : Ratio
National_SUB1_Top_10_Percent
Indicates the top 10 percentage for SUB1 Measure.
integer
level : Ratio
National_SUB1_Numerator
Indicates the overall Numerator value for SUB1 Measure.
integer
level : Ratio
National_SUB1_Denominator
Indicates the overall Denominator value for SUB1 Measure.
integer
level : Ratio
National_SUB2_2a_Measure_Description
Description of Substance Use Treatment Measure. It is described as Alcohol Use Brief Intervention Provided or Offered.
string
-
National_SUB2_Percent
Indicates the overall percentage for SUB2 Measure.
number
level : Ratio
National_SUB2_Top_10_Percent
Indicates the top 10 percentage for SUB2 Measure.
integer
level : Ratio
National_SUB2_Numerator
Indicates the overall percentage for SUB2 Measure.
number
level : Ratio
National_SUB2_Denominator
Indicates the overall Denominator value for SUB2 Measure.
integer
level : Ratio
National_SUB2a_Percent
Indicates the overall percentage for SUB2a Measure.
number
level : Ratio
National_SUB2a_Top_10_Percent
Indicates the top 10 percentage for SUB2 Measure.
integer
level : Ratio
National_SUB2a_Numerator
Indicates the overall Numerator value for SUB2a Measure.
integer
level : Ratio
National_SUB2a_Denominator
Indicates the overall Denominator value for SUB2a Measure.
integer
level : Ratio
National_SUB3_3a_Measure_Description
Description of National-wise Substance Use Treatment Measure. SUB3 3a is described as use of Alcohol and other Drug Use Disorder Treatment Provided or Offered at Discharge.
string
-
National_SUB3_Percent
Indicates the overall percentage for SUB3 Measure.
integer
level : Ratio
National_SUB3_Top_10_Percent
Indicates the top 10 percentage for SUB3 Measure.
integer
level : Ratio
National_SUB3a_Percent
Indicates the overall percentage for SUB3a Measure.
integer
level : Ratio
National_SUB3a_Top_10_Percent
Indicates the top 10 percentage for SUB3a Measure.
integer
level : Ratio
National_TOB1_Measure_Description
Description of Substance Use Treatment Measure. TOB1 is described as Tobacco Use Screening. Measures the percent of patients age 18 years or older who were screened for tobacco use, using a validated screening questionnaire for unhealthy tobacco use within three days of admission as a proportion of patients discharged.
string
-
National_TOB1_Percent
Indicates the overall percentage for TOB1 Measure.
number
level : Ratio
National_TOB1_Top_10_Percent
Indicates the top 10 percentage for TOB1 Measure.
integer
level : Ratio
National_TOB1_Numerator
Indicates the overall Numerator value for TOB1 Measure.
integer
level : Ratio
National_TOB1_Denominator
Indicates the overall Denominator value for TOB1 Measure.
integer
level : Ratio
National_TOB2_2a_Measure_Description
Description of Substance Use Treatment Measure. It is described as National Tobacco Use Treatment during the hospital stay.
string
-
National_TOB2_Percent
Indicates the overall percentage for TOB2 Measure.
number
level : Ratio
National_TOB2_Top_10_Percent
Indicates the top 10 percentage for TOB2 Measure.
integer
level : Ratio
National_TOB2_Numerator
Indicates the overall Numerator value for TOB2 Measure.
integer
level : Ratio
National_TOB2_Denominator
Indicates the overall Denominator value for TOB2 Measure.
integer
level : Ratio
National_TOB2a_Percent
Indicates the overall percentage for TOB2 Measure.
number
level : Ratio
National_TOB2a_Top_10_Percent
Indicates the top 10 percentage for TOB2 Measure.
integer
level : Ratio
National_TOB2a_Numerator
Indicates the overall Numerator value for TOB2a Measure.
integer
level : Ratio
National_TOB2a_Denominator
Indicates the overall Denominator value for TOB2a Measure.
integer
level : Ratio
National_TOB3_3a_Measure_Description
Description of Substance Use Treatment Measure. It is described as National Tobacco Use Treatment provided or Offered at Discharge.
string
-
National_TOB3_Percent
Indicates the overall percentage for TOB3 Measure.
number
level : Ratio
National_TOB3_Top_10_Percent
Indicates the top 10 percentage for TOB3 Measure.
integer
level : Ratio
National_TOB3_Numerator
Indicates the overall Numerator value for TOB3 Measure.
integer
level : Ratio
National_TOB3_Denominator
Indicates the overall Denominator value for TOB3 Measure.
integer
level : Ratio
National_TOB3a_Percent
Indicates the overall percentage for TOB3 Measure.
number
level : Ratio
National_TOB3a_Top_10_Percent
Indicates the top 10 percentage for TOB3a Measure.
integer
level : Ratio
National_TOB3a_Numerator
Indicates the overall Numerator value for TOB3a Measure.
integer
level : Ratio
National_TOB3a_Denominator
Indicates the overall Denominator value for TOB3a Measure.
integer
level : Ratio
National_PEoC_Measure_Description
Description of Patient Experience of Care Measure. PEOC is a structural measure. This is a mandatory attestation: does the facility routinely assess patient experience of care using a standardized collection protocol and a structured instrument, and if yes, which tool did they use.
string
-
National_PEoC_Yes_Count
Indicates the number of 'Yes' counts for Patient Experience of care Measure.
integer
level : Ratio
National_PEoC_No_Count
Indicates the number of 'No' counts for Patient Experience of care Measure.
integer
level : Ratio
National_PEoC_Yes_Percent
Indicates the Percent of 'Yes' for Patient Experience of care Measure.
number
level : Ratio
National_PEoC_No_Percent
Indicates the Percent of 'No' for Patient Experience of care Measure.
number
level : Ratio
National_EHR_Use_Measure_Description
Description of facility's highest level typical use of an Electronic Health Records (EHR) Measure. EHR is a structural measure. This is a mandatory attestation: identify the degree to which the facility employs EHR systems in their service program and use such systems to support health information exchange at times of transitions in care.
string
-
National_EHR_Paper_Count
Indicates the number of 'Paper' Records as per Electronic Health Record Measure.
integer
level : Ratio
National_EHR_Non_Certified_Count
Indicates the number of 'Non-Certified' Records as per Electronic Health Record Measure.
integer
level : Ratio
National_EHR_Certified_Count
Indicates the number of 'Certified' Records as per Electronic Health Record Measure.
integer
level : Ratio
National_EHR_Paper_Percent
Indicates the Percent of 'Paper' Records as per Electronic Health Record Measure.
number
level : Ratio
National_EHR_Non_Certified_Percent
Indicates the Percent of 'Non-Certified' Records as per Electronic Health Record Measure
number
level : Ratio
National_EHR_Certified_Percent
Indicates the Percent of 'Certified' Records as per Electronic Health Record Measure
number
level : Ratio
National_EHR_HISP_Measure_Description
Description of Facility exchanged interoperable health information with a health information service provider (HISP) at times of transitions in care.
string
-
National_EHR_HISP_Yes_Count
Indicates the number of 'Yes' counts for Electronic Health Record (EHR) Health Information Service Provider (HISP) Measure.
integer
level : Ratio
National_EHR_HISP_No_Count
Indicates the number of 'No' counts for Electronic Health Record (EHR) Health Information Service Provider (HISP) Measure.
integer
level : Ratio
National_EHR_HISP_Yes_Percent
Indicates the percent of 'Yes' for Electronic Health Record (EHR) Health Information Service Provider (HISP) Measure.
integer
level : Ratio
National_EHR_HISP_No_Percent
Indicates the percent of 'No' for Electronic Health Record (EHR) Health Information Service Provider (HISP) Measure.
integer
level : Ratio
National_HIE_Measure_Description
Description of Health Information Exchange Measure. Used at times of transitions in care.
string
-
National_HIE_Yes_Count
Indicates the number of 'Yes' counts for Health Information Exchange Measure.
integer
level : Ratio
National_HIE_No_Count
Indicates the number of 'No' counts for Health Information Exchange Measure.
integer
level : Ratio
National_HIE_Yes_Percent
Indicates the Percent of 'Yes' for Health Information Exchange Measure.
number
level : Ratio
National_HIE_No_Percent
Indicates the Percent of 'No' for Health Information Exchange Measure.
number
level : Ratio
National_HIE_Start_Date
The first day of HIE data measures was collected. The date format is YYYY-MM-DD.
date
-
National_HIE_End_Date
The last day of HIE data measures was collected. The date format is YYYY-MM-DD.
date
-
National_TR1_Measure_Description
Description of Transition record with specified elements received by discharged patients (TR1).
string
-
National_TR1_Percent
Indicates the percentage of Transition Record with specified elements (TR1) Measure.
integer
level : Ratio
National_TR1_Top_10_Percent
Indicates the top 10 percentage for Transition Record with specified elements (TR1) Measure.
integer
level : Ratio
National_TR2_Measure_Description
Description of Timely Transmission of transition record (TR2) Measure.
string
-
National_TR2_Percent
Indicates the percentage of Timely Transmission of transition record (TR2) Measure.
integer
level : Ratio
National_TR2_Top_10_Percent
Indicates the top 10 percentage for Timely Transmission of transition record (TR2) Measure.
integer
level : Ratio
National_TR2_Start_Date
The first day of TR2 data measures was collected. The date format is YYYY-MM-DD.
date
-
National_TR2_End_Date
The last day of TR2 data measures was collected. The date format is YYYY-MM-DD.
date
-
National_FUH_Measure_Description
Description of Follow-Up after Hospitalization (FUH) Measure. FUH for Mental Illness measures the percentage of discharged patients age 6 years or older who had an outpatient visit, an intensive outpatient encounter, or a partial hospitalization with a mental health practitioner, within 7 days and 30 days of discharge. CMS will calculate these measures based on Medicare claims data.
string
-
National_FUH30_Percent
Indicates the percent for Follow-up after Hospitalization (FUH) for Mental Illness of 30-Days.
number
level : Ratio
National_FUH30_Top_10_Percent
Indicates the top 10 percentage for Follow-up after Hospitalization (FUH) for Mental Illness of 30-Days.
number
level : Ratio
National_FUH7_Percent
Indicates the percent for Follow-up after Hospitalization (FUH) for Mental Illness of 7-Days.
number
level : Ratio
National_FUH7_Top_10_Percent
Indicates the top 10 percntage for Follow-up after Hospitalization (FUH) for Mental Illness of 7-Days.
number
level : Ratio
National_FUH_Measure_Start_Date
The first day of FUH data measures was collected. The date format is YYYY-MM-DD.
date
-
National_FUH_Measure_End_Date
The last day of FUH data measures was collected. The date format is YYYY-MM-DD.
date
-
National_MedCont_Measure_Description
It is described as Medication Continuation Following Inpatient Psychiatric Discharge.
string
-
National_MedCont_Percent
Indicates the overall percentage for MedCon Measure.
number
level : Ratio
National_MedCont_Top_10_Percent
Indicates the top 10 percentage for Medication Continuation (MedCont) Following Inpatient Psychiatric Discharge Measure.
number
level : Ratio
National_MedCont_Measure_Start_Date
The first day the data regarding MedCont measures was collected. The date format is YYYY-MM-DD.
date
-
National_MedCont_Measure_End_Date
The last day the data regarding MedCont measures was collected. The date format is YYYY-MM-DD.
date
-
National_READM30_IPF_Measure_Description
Description of Patients readmitted to any hospital within 30 days of discharge from the inpatient psychiatric facility (READM-30-IPF).
string
-
National_READM30_IPF_National_Rate
Indicates the national rate for Patients readmitted to any hospital within 30 days of discharge from the inpatient psychiatric facility (READM-30-IPF).
number
level : Ratio
National_READM30_IPF_Number_IPFs_Worse
Indicates the number of IPFs worse for rate of readmission after 30 days of discharge from hospital.
integer
level : Ratio
National_READM30_IPF_Number_IPFs_Same
Indicates the Same number of IPFs for rate of readmission after 30 days of discharge from hospital.
integer
level : Ratio
National_READM30_IPF_Number_IPFs_Better
Indicates the number of IPFs Better for rate of readmission after 30 days of discharge from hospital.
integer
level : Ratio
National_READM30_IPF_Number_IPFs_Too_Few
Indicates the number of IPFs Too Few for rate of readmission after 30 days of discharge from hospital.
integer
level : Ratio
National_READM30_IPF_Start_Date
The first day the data regarding READM30 IPF Measure was collected. The date format is YYYY-MM-DD.
date
-
National_READM30_IPF_End_Date
The last day the data regarding READM30 IPF Measure was collected. The date format is YYYY-MM-DD.
date
-
National_IMM2_Measure_Description
Indicates the description of National Influenza Immunization Measure.
string
-
National_IMM2_Percent
Indicates the overall percentage for IMM2 Measure.
number
level : Ratio
National_IMM2_Top_10_Percent
Indicates the top 10 percentage for IMM2 Measure.
integer
level : Ratio
National_IMM2_Numerator
Indicates the overall Numerator value for IMM2 Measure.
integer
level : Ratio
National_IMM2_Denominator
Indicates the overall Denominator value for IMM2 Measure.
integer
level : Ratio
National_HCP_Measure_Description
Indicates the description of National Healthcare Personnel Influenza Vaccination Measure.
string
-
National_HCP_Percent
Indicates the overall percentage for HCP Measure.
number
level : Ratio
National_HCP_Numerator
Indicates the overall Numerator value for HCP Measure.
integer
level : Ratio
National_HCP_Denominator
Indicates the overall Denominator value for HCP Measure.
integer
level : Ratio
National_Flu_Season_Start_Date
The first day of the Flu Season data measures was collected. The date format is YYYY-MM-DD.
date
-
National_Flu_Season_End_Date
The last day of the Flu Season data measures was collected. The date format is YYYY-MM-DD.
date
-
National_IPFQR_HCP_COVID19_Measure_Description
It describes inpatient psychiatric hospital facility quality measures percentage of healthcare personnel who completed COVID-19 primary vaccination series (IPFQR- HCP COVID-19).
string
-
National_IPFQR_HCP_COVID19_Percent
Indicates the overall percentage for IPFQR HCP COVID19 Measure.
number
level : Ratio
National_IPFQR_HCP_COVID19_Start_Date
The first day the data regarding IPFQR HCP COVID19 Measure was collected. The date format is YYYY-MM-DD.
date
-
National_IPFQR_HCP_COVID19_End_Date
The last day the data regarding IPFQR HCP COVID19 Measure was collected. The date format is YYYY-MM-DD.
date
-
Data Preview
Year
National HBIPS2 Measure Description
National HBIPS2 Overall Rate Per 1000
National HBIPS2 Overall Numerator
National HBIPS2 Overall Denominator
National HBIPS2 1 to 12 Rate Per 1000
National HBIPS2 1 to 12 Numerator
National HBIPS2 1 to 12 Denominator
National HBIPS2 13 to 17 Rate Per 1000
National HBIPS2 13 to 17 Numerator
National HBIPS2 13 to 17 Denominator
National HBIPS2 18 to 64 Rate Per 1000
National HBIPS2 18 to 64 Numerator
National HBIPS2 18 to 64 Denominator
National HBIPS2 65 Over Rate Per 1000
National HBIPS2 65 Over Numerator
National HBIPS2 65 Over Denominator
National HBIPS3 Measure Description
National HBIPS3 Overall Rate Per 1000
National HBIPS3 Overall Numerator
National HBIPS3 Overall Denominator
National HBIPS3 1 to 12 Rate Per 1000
National HBIPS3 1 to 12 Numerator
National HBIPS3 1 to 12 Denominator
National HBIPS3 13 to 17 Rate Per 1000
National HBIPS3 13 to 17 Numerator
National HBIPS3 13 to 17 Denominator
National HBIPS3 18 to 64 Rate Per 1000
National HBIPS3 18 to 64 Numerator
National HBIPS3 18 to 64 Denominator
National HBIPS3 65 Over Rate Per 1000
National HBIPS3 65 Over Numerator
National HBIPS3 65 Over Denominator
National HBIPS4 Measure Description
National HBIPS4 Overall Percent of Total
National HBIPS4 Overall Numerator
National HBIPS4 Overall Denominator
National HBIPS4 1 to 12 Percent of Total
National HBIPS4 1 to 12 Numerator
National HBIPS4 1 to 12 Denominator
National HBIPS4 13 to 17 Percent of Total
National HBIPS4 13 to 17 Numerator
National HBIPS4 13 to 17 Denominator
National HBIPS4 18 to 64 Percent of Total
National HBIPS4 18 to 64 Numerator
National HBIPS4 18 to 64 Denominator
National HBIPS4 65 Over Percent of Total
National HBIPS4 65 Over Numerator
National HBIPS4 65 Over Denominator
National HBIPS5 Measure Description
National HBIPS5 Overall Percent of Total
National HBIPS5 Top 10 Percent
National HBIPS5 Overall Numerator
National HBIPS5 Overall Denominator
National HBIPS5 1 to 12 Percent of Total
National HBIPS5 1 to 12 Numerator
National HBIPS5 1 to 12 Denominator
National HBIPS5 13 to 17 Percent of Total
National HBIPS5 13 to 17 Numerator
National HBIPS5 13 to 17 Denominator
National HBIPS5 18 to 64 Percent of Total
National HBIPS5 18 to 64 Numerator
National HBIPS5 18 to 64 Denominator
National HBIPS5 65 Over Percent of Total
National HBIPS5 65 Over Numerator
National HBIPS5 65 Over Denominator
National HBIPS6 Measure Description
National HBIPS6 Overall Percent of Total
National HBIPS6 Overall Numerator
National HBIPS6 Overall Denominator
National HBIPS6 1 to 12 Percent of Total
National HBIPS6 1 to 12 Numerator
National HBIPS6 1 to 12 Denominator
National HBIPS6 13 to 17 Percent of Total
National HBIPS6 13 to 17 Numerator
National HBIPS6 13 to 17 Denominator
National HBIPS6 18 to 64 Percent of Total
National HBIPS6 18 to 64 Numerator
National HBIPS6 18 to 64 Denominator
National HBIPS6 65 Over Percent of Total
National HBIPS6 65 Over Numerator
National HBIPS6 65 Over Denominator
National HBIPS7 Measure Description
National HBIPS7 Overall Percent of Total
National HBIPS7 Overall Numerator
National HBIPS7 Overall Denominator
National HBIPS7 1 to 12 Percent of Total
National HBIPS7 1 to 12 Numerator
National HBIPS7 1 to 12 Denominator
National HBIPS7 13 to 17 Percent of Total
National HBIPS7 13 to 17 Numerator
National HBIPS7 13 to 17 Denominator
National HBIPS7 18 to 64 Percent of Total
National HBIPS7 18 to 64 Numerator
National HBIPS7 18 to 64 Denominator
National HBIPS7 65 Over Percent of Total
National HBIPS7 65 Over Numerator
National HBIPS7 65 Over Denominator
National SMD Measure Description
National SMD Percent
National SMD Top 10 Percent
National SUB1 Measure Description
National SUB1 Percent
National SUB1 Top 10 Percent
National SUB1 Numerator
National SUB1 Denominator
National SUB2 2a Measure Description
National SUB2 Percent
National SUB2 Top 10 Percent
National SUB2 Numerator
National SUB2 Denominator
National SUB2a Percent
National SUB2a Top 10 Percent
National SUB2a Numerator
National SUB2a Denominator
National SUB3 3a Measure Description
National SUB3 Percent
National SUB3 Top 10 Percent
National SUB3a Percent
National SUB3a Top 10 Percent
National TOB1 Measure Description
National TOB1 Percent
National TOB1 Top 10 Percent
National TOB1 Numerator
National TOB1 Denominator
National TOB2 2a Measure Description
National TOB2 Percent
National TOB2 Top 10 Percent
National TOB2 Numerator
National TOB2 Denominator
National TOB2a Percent
National TOB2a Top 10 Percent
National TOB2a Numerator
National TOB2a Denominator
National TOB3 3a Measure Description
National TOB3 Percent
National TOB3 Top 10 Percent
National TOB3 Numerator
National TOB3 Denominator
National TOB3a Percent
National TOB3a Top 10 Percent
National TOB3a Numerator
National TOB3a Denominator
National PEoC Measure Description
National PEoC Yes Count
National PEoC No Count
National PEoC Yes Percent
National PEoC No Percent
National EHR Use Measure Description
National EHR Paper Count
National EHR Non Certified Count
National EHR Certified Count
National EHR Paper Percent
National EHR Non Certified Percent
National EHR Certified Percent
National EHR HISP Measure Description
National EHR HISP Yes Count
National EHR HISP No Count
National EHR HISP Yes Percent
National EHR HISP No Percent
National HIE Measure Description
National HIE Yes Count
National HIE No Count
National HIE Yes Percent
National HIE No Percent
National HIE Start Date
National HIE End Date
National TR1 Measure Description
National TR1 Percent
National TR1 Top 10 Percent
National TR2 Measure Description
National TR2 Percent
National TR2 Top 10 Percent
National TR2 Start Date
National TR2 End Date
National FUH Measure Description
National FUH30 Percent
National FUH30 Top 10 Percent
National FUH7 Percent
National FUH7 Top 10 Percent
National FUH Measure Start Date
National FUH Measure End Date
National MedCont Measure Description
National MedCont Percent
National MedCont Top 10 Percent
National MedCont Measure Start Date
National MedCont Measure End Date
National READM30 IPF Measure Description
National READM30 IPF National Rate
National READM30 IPF Number IPFs Worse
National READM30 IPF Number IPFs Same
National READM30 IPF Number IPFs Better
National READM30 IPF Number IPFs Too Few
National READM30 IPF Start Date
National READM30 IPF End Date
National IMM2 Measure Description
National IMM2 Percent
National IMM2 Top 10 Percent
National IMM2 Numerator
National IMM2 Denominator
National HCP Measure Description
National HCP Percent
National HCP Numerator
National HCP Denominator
National Flu Season Start Date
National Flu Season End Date
National IPFQR HCP COVID19 Measure Description
National IPFQR HCP COVID19 Percent
National IPFQR HCP COVID19 Start Date
National IPFQR HCP COVID19 End Date
2017
Hours of physical-restraint use
0.36
250637.92
29102920
Hours of seclusion use
0.23
155194.0
28425227.0
Patients discharged on multiple antipsychotic medications with appropriate justification
66
100.0
Screening for metabolic disorders (SMD)
65.0
99.0
Percent of patients screened for alcohol use using a validated screening questionnaire
92.0
100.0
Alcohol use brief intervention provided or offered
79.0
100.0
72.0
100.0
Alcohol and other drug use disorder treatment provided or offered at discharge
65.0
98.0
54.0
93.0
Tobacco use screening
96.0
100.0
Tobacco use treatment provided or offered
80.0
100.0
45.0
86.0
Tobacco use treatment provided or offered at discharge
54.0
97.0
15.0
57.0
Patient experience of care (PEoC) routinely assessed using standardized collection protocol
1256.0
360.0
78.0
22.0
Facility's highest level typical use of an electronic health records system (EHR)
913.0
29.0
674.0
56.0
2.0
42.0
Facility exchanged interoperable health information with a health information service provider (HISP) at times of transitions in care
632.0
984.0
39.0
61.0
Transition record with specified elements received by discharged patients (TR1)
50.0
98.0
Timely transmission of transition record (TR2)
45.0
97.0
2017-01-01
2017-12-31
Percent of patients receiving follow-up care within 30 days (FUH-30) or within 7 days (FUH-7) after hospitalization for mental illness
52.7
71.7
30.6
47.9
2016-07-01
Patients readmitted to any hospital within 30 days of discharge from the inpatient psychiatric facility (READM-30-IPF)
20.1
177.0
1325.0
109.0
81.0
2015-07-01
Influenza immunization (IPFQR-IMM-2)
82.0
100.0
Influenza vaccination coverage among healthcare personnel (HCP)
82.0
2017-10-01
2018-03-31
2016
Hours of physical-restraint use
0.44
261956.16
24715119
Hours of Seclusion
0.29
172196.0
24616982.0
Patients discharged on multiple antipsychotic medications
Patients discharged on multiple antipsychotic medications with appropriate justification
59
32436.0
55361.0
Post-discharge continuing care plan created
Post-discharge continuing care plan transmitted to the next level of care provider upon discharge
Alcohol Use Screening
92.0
624222.0
676190.0
Alcohol Use Brief Intervention Provided or Offered
70.0
134155.0
93798.0
62.0
82857.0
134155.0
Tobacco Use Screening
96.28
711771.0
739291.0
Tobacco Use Treatment (during the hospital stay)
76.0
262770.0
343764.0
41.12
141343.0
343764.0
Tobacco Use Treatment Provided or Offered at Discharge
41.0
126539.0
310586.0
9.43
29296.0
310586.0
Assessment of Patient Experience of Care
1243.0
389.0
76.0
24.0
Highest level typical use of an EHR system
944.0
38.0
650.0
57.84
2.33
40.0
Interoperable health information exchanged with HISP
619.0
1013.0
37.93
62.07
2016-01-01
2016-12-31
Percent of patients receiving follow-up care within 30 days (FUH-30) or within 7 days (FUH-7) after hospitalization for mental illness
2015-07-01
Influenza Immunization
80.98
406603.0
502083.0
Healthcare Personnel Influenza Vaccination
80.0
473974.0
589537.0
2016-10-01
2017-03-31
2014
Hours of physical-restraint use
0.41
322218.26
32417260
0.25
5460.0
897288.0
0.19
12517.0
2791775.0
0.31
176304.76
23380645.0
1.0
127936.41
5347552.0
Hours of Seclusion
0.21
165774.0
32297340.0
0.0
10071.0
892761.0
0.0
13009.0
2762143.0
0.0
137813.0
23579741.0
0.0
4881.0
5062695.0
Patients discharged on multiple antipsychotic medications
9.0
57288.0
607754.0
2.0
586.0
27666.0
4.0
2353.0
59699.0
11.39
44633.0
392000.0
8.0
9716.0
128389.0
Patients discharged on multiple antipsychotic medications with appropriate justification
37
32451.0
88613.0
32.0
322.0
1014.0
46.0
1732.0
3732.0
40.0
24925.0
62732.0
26.0
5472.0
21135.0
Post-discharge continuing care plan created
85.0
766795.0
904926.0
93.0
43381.0
46815.0
90.0
93500.0
104039.0
85.0
483601.0
572025.0
80.0
146313.0
182047.0
Post-discharge continuing care plan transmitted to the next level of care provider upon discharge
78.0
699089.0
902065.0
86.0
40089.0
46807.0
83.0
86461.0
104023.0
77.0
440189.0
571708.0
74.0
132350.0
179527.0
Alcohol Use Screening
71.0
490784.0
691196.0
Alcohol Use Brief Intervention Provided or Offered
Tobacco Use Screening
Tobacco Use Treatment (during the hospital stay)
Tobacco Use Treatment Provided or Offered at Discharge
Assessment of Patient Experience of Care
1177.0
450.0
72.0
28.0
Highest level typical use of an EHR system
1039.0
44.0
544.0
63.86
2.7
33.0
Interoperable health information exchanged with HISP
477.0
1150.0
29.32
70.68
2014-01-01
2014-12-31
Percent of patients receiving follow-up care within 30 days (FUH-30) or within 7 days (FUH-7) after hospitalization for mental illness
Influenza Immunization
Healthcare Personnel Influenza Vaccination
2018
Hours of physical-restraint use
0.36
250637.92
29102920
Hours of seclusion use
0.23
155194.0
28425227.0
Patients discharged on multiple antipsychotic medications with appropriate justification
66
100.0
Screening for metabolic disorders (SMD)
65.0
99.0
Percent of patients screened for alcohol use using a validated screening questionnaire
92.0
100.0
Alcohol use brief intervention provided or offered
79.0
100.0
72.0
100.0
Alcohol and other drug use disorder treatment provided or offered at discharge
65.0
98.0
54.0
93.0
Tobacco use screening
96.0
100.0
Tobacco use treatment provided or offered
80.0
100.0
45.0
86.0
Tobacco use treatment provided or offered at discharge
54.0
97.0
15.0
57.0
Patient experience of care (PEoC) routinely assessed using standardized collection protocol
1256.0
360.0
78.0
22.0
Facility's highest level typical use of an electronic health records system (EHR)
913.0
29.0
674.0
56.0
2.0
42.0
Facility exchanged interoperable health information with a health information service provider (HISP) at times of transitions in care
632.0
984.0
39.0
61.0
Transition record with specified elements received by discharged patients (TR1)
50.0
98.0
Timely transmission of transition record (TR2)
45.0
97.0
2017-01-01
2017-12-31
Percent of patients receiving follow-up care within 30 days (FUH-30) or within 7 days (FUH-7) after hospitalization for mental illness
52.7
71.7
30.6
47.9
2016-07-01
2016-07-31
Patients readmitted to any hospital within 30 days of discharge from the inpatient psychiatric facility (READM-30-IPF)
20.1
177.0
1325.0
109.0
81.0
2015-07-01
Influenza immunization (IPFQR-IMM-2)
82.0
100.0
Influenza vaccination coverage among healthcare personnel (HCP)
82.0
2017-10-01
2018-03-31
2019
Hours of physical-restraint use
0.38
245395.55
26707181
Hours of seclusion use
0.29
183881.0
26534482.0
Patients discharged on multiple antipsychotic medications with appropriate justification
61
100.0
Screening for metabolic disorders (SMD)
74.0
100.0
Alcohol use brief intervention provided or offered
83.0
100.0
75.0
100.0
Alcohol and other drug use disorder treatment provided or offered at discharge
70.0
100.0
59.0
98.0
Tobacco use treatment provided or offered
81.0
100.0
46.0
88.0
Tobacco use treatment provided or offered at discharge
57.0
99.0
18.0
71.0
Transition record with specified elements received by discharged patients (TR1)
63.0
99.0
Timely transmission of transition record (TR2)
55.0
98.0
2018-01-01
2018-12-31
Percent of patients receiving follow-up care within 30 days (FUH-30) or within 7 days (FUH-7) after hospitalization for mental illness
49.9
69.2
27.7
45.2
2017-07-01
2018-06-30
Patients readmitted to any hospital within 30 days of discharge from the inpatient psychiatric facility (READM-30-IPF)
20.1
154.0
1344.0
106.0
90.0
2016-07-01
2018-06-30
Influenza immunization (IPFQR-IMM-2)
83.0
100.0
2018-10-01
2019-03-31
2020
Hours of physical-restraint use
0.34
232198.84
28696274
28696274.0
Hours of seclusion use
Patients discharged on multiple antipsychotic medications with appropriate justification
65
100.0
2021
Hours of physical-restraint use
0.3
230923.37
32027727
Hours of seclusion use
0.29
226282.0
32027727.0
Patients discharged on multiple antipsychotic medications with appropriate justification
64
100.0
Screening for metabolic disorders (SMD)
77.0
100.0
Alcohol use brief intervention provided or offered
79.0
100.0
72.0
100.0
Alcohol and other drug use disorder treatment provided or offered at discharge
75.0
100.0
75.0
100.0
Tobacco use treatment provided or offered
80.0
100.0
45.0
89.0
Tobacco use treatment provided or offered at discharge
61.0
100.0
22.0
83.0
Transition record with specified elements received by discharged patients (TR1)
69.0
100.0
Timely transmission of transition record (TR2)
60.0
98.0
2020-01-01
2020-12-31
Percent of patients receiving follow-up care within 30 days (FUH-30) or within 7 days (FUH-7) after hospitalization for mental illness
49.5
71.0
27.9
46.2
2019-07-01
2019-12-31
2020-10-01
2021-03-31
2022
Hours of physical-restraint use
0.26
199420.48
31872211
Hours of seclusion use
0.25
193385.33
31872211.0
Patients discharged on multiple antipsychotic medications with appropriate justification
64
100.0
Screening for metabolic disorders (SMD)
77.0
100.0
Alcohol use brief intervention provided or offered
79.0
100.0
72.0
100.0
Alcohol and other drug use disorder treatment provided or offered at discharge
75.0
100.0
63.0
99.0
Tobacco use treatment provided or offered
81.0
100.0
45.0
89.0
Tobacco use treatment provided or offered at discharge
61.0
99.0
21.0
83.0
Transition record with specified elements received by discharged patients (TR1)
69.0
100.0
Timely transmission of transition record (TR2)
60.0
98.0
2020-01-01
2020-12-31
Percent of patients receiving follow-up care within 30 days (FUH-30) or within 7 days (FUH-7) after hospitalization for mental illness
49.5
71.0
27.9
46.2
2019-07-01
2019-12-01
Medication Continuation Following Inpatient Psychiatric Discharge
73.1
83.7
2018-07-01
2019-12-01
Patients readmitted to any hospital within 30 days of discharge from the inpatient psychiatric facility (READM-30-IPF)
20.2
115.0
1354.0
59.0
108.0
2018-07-01
2019-12-01
Influenza immunization (IPFQR-IMM-2)
79.0
100.0
2020-10-01
2021-03-31
Percentage of healthcare personnel who completed COVID-19 primary vaccination series (IPFQR-HCP COVID-19)